Representative(s):

Barry Eberhardt

414-550-4975
barry.eberhardt@astrazeneca.com

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. 

Visit our website to learn more:  www.astrazeneca-us.com 
Follow us on Twitter @AstraZenecaUS.

TAGRISSO®  (osimertinib) US Prescribing Information

LYNPARZA® (olaparib) US Prescribing Information 

ENHERTU® (fam-trastuzumab deruxtecan-nxki) Full US Prescribing Information. See Boxed WARNINGS 

IMFINZI® (durvalumab) US Prescribing Information

CALQUENCE® (acalabrutinib) US Prescribing Information

CALQUENCE® (acalabrutinib) US HCP Website

LYNPARZA® (olaparib) US HCP Website

IMFINZI® (durvalumab) US HCP Website

TAGRISSO® (osimertinib) US HCP Website

ENHERTU® (fam-trastuzumab deruxtecan-nxki) US HCP Website. See Full Prescribing Information and Boxed WARNINGS